PortfoliosLab logo
CTAS vs. CI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CTAS and CI is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

CTAS vs. CI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cintas Corporation (CTAS) and Cigna Corporation (CI). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

CTAS:

1.09

CI:

-0.31

Sortino Ratio

CTAS:

1.52

CI:

-0.33

Omega Ratio

CTAS:

1.24

CI:

0.96

Calmar Ratio

CTAS:

1.42

CI:

-0.37

Martin Ratio

CTAS:

3.60

CI:

-0.82

Ulcer Index

CTAS:

7.73%

CI:

12.16%

Daily Std Dev

CTAS:

25.14%

CI:

27.43%

Max Drawdown

CTAS:

-65.32%

CI:

-84.34%

Current Drawdown

CTAS:

-3.16%

CI:

-15.04%

Fundamentals

Market Cap

CTAS:

$86.49B

CI:

$81.04B

EPS

CTAS:

$4.31

CI:

$17.93

PE Ratio

CTAS:

49.70

CI:

16.92

PEG Ratio

CTAS:

3.81

CI:

0.59

PS Ratio

CTAS:

8.53

CI:

0.32

PB Ratio

CTAS:

18.93

CI:

2.00

Total Revenue (TTM)

CTAS:

$10.14B

CI:

$254.47B

Gross Profit (TTM)

CTAS:

$5.02B

CI:

$254.47B

EBITDA (TTM)

CTAS:

$2.84B

CI:

$11.02B

Returns By Period

In the year-to-date period, CTAS achieves a 20.03% return, which is significantly higher than CI's 12.40% return. Over the past 10 years, CTAS has outperformed CI with an annualized return of 27.46%, while CI has yielded a comparatively lower 9.61% annualized return.


CTAS

YTD

20.03%

1M

5.13%

6M

1.22%

1Y

27.18%

5Y*

32.32%

10Y*

27.46%

CI

YTD

12.40%

1M

-6.02%

6M

-3.77%

1Y

-8.48%

5Y*

11.86%

10Y*

9.61%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CTAS vs. CI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CTAS
The Risk-Adjusted Performance Rank of CTAS is 8383
Overall Rank
The Sharpe Ratio Rank of CTAS is 8686
Sharpe Ratio Rank
The Sortino Ratio Rank of CTAS is 7878
Sortino Ratio Rank
The Omega Ratio Rank of CTAS is 8282
Omega Ratio Rank
The Calmar Ratio Rank of CTAS is 8989
Calmar Ratio Rank
The Martin Ratio Rank of CTAS is 8282
Martin Ratio Rank

CI
The Risk-Adjusted Performance Rank of CI is 2828
Overall Rank
The Sharpe Ratio Rank of CI is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of CI is 2626
Sortino Ratio Rank
The Omega Ratio Rank of CI is 2626
Omega Ratio Rank
The Calmar Ratio Rank of CI is 2626
Calmar Ratio Rank
The Martin Ratio Rank of CI is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CTAS vs. CI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cintas Corporation (CTAS) and Cigna Corporation (CI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current CTAS Sharpe Ratio is 1.09, which is higher than the CI Sharpe Ratio of -0.31. The chart below compares the historical Sharpe Ratios of CTAS and CI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

CTAS vs. CI - Dividend Comparison

CTAS's dividend yield for the trailing twelve months is around 0.71%, less than CI's 1.85% yield.


TTM20242023202220212020201920182017201620152014
CTAS
Cintas Corporation
0.71%0.80%0.83%0.93%0.77%0.79%0.95%1.22%1.04%1.15%1.15%2.17%
CI
Cigna Corporation
1.85%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%0.04%

Drawdowns

CTAS vs. CI - Drawdown Comparison

The maximum CTAS drawdown since its inception was -65.32%, smaller than the maximum CI drawdown of -84.34%. Use the drawdown chart below to compare losses from any high point for CTAS and CI. For additional features, visit the drawdowns tool.


Loading data...

Volatility

CTAS vs. CI - Volatility Comparison

The current volatility for Cintas Corporation (CTAS) is 5.57%, while Cigna Corporation (CI) has a volatility of 8.70%. This indicates that CTAS experiences smaller price fluctuations and is considered to be less risky than CI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

CTAS vs. CI - Financials Comparison

This section allows you to compare key financial metrics between Cintas Corporation and Cigna Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00B20.00B30.00B40.00B50.00B60.00B70.00B20212022202320242025
2.61B
65.50B
(CTAS) Total Revenue
(CI) Total Revenue
Values in USD except per share items

CTAS vs. CI - Profitability Comparison

The chart below illustrates the profitability comparison between Cintas Corporation and Cigna Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%100.0%20212022202320242025
50.6%
100.0%
(CTAS) Gross Margin
(CI) Gross Margin
CTAS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cintas Corporation reported a gross profit of 1.32B and revenue of 2.61B. Therefore, the gross margin over that period was 50.6%.

CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Cigna Corporation reported a gross profit of 65.50B and revenue of 65.50B. Therefore, the gross margin over that period was 100.0%.

CTAS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cintas Corporation reported an operating income of 609.85M and revenue of 2.61B, resulting in an operating margin of 23.4%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Cigna Corporation reported an operating income of 1.65B and revenue of 65.50B, resulting in an operating margin of 2.5%.

CTAS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cintas Corporation reported a net income of 463.50M and revenue of 2.61B, resulting in a net margin of 17.8%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Cigna Corporation reported a net income of 1.32B and revenue of 65.50B, resulting in a net margin of 2.0%.